Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 8, 2005
Refining molecular analysis in the pathways of colorectal carcinogenesis
Andrew Rowan, Sarah Halford, Michelle Gaasenbeek, et al.
British Journal of Cancer
|
February 21, 2020
A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
Rosie McNeillis, Alastair Greystoke, Jon Walton, et al.
British Journal of Cancer
|
March 23, 2016
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
Yvette Drew, Jonathan Ledermann, Geoff Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors
Dan M Patterson, Martin Zweifel, Mark R Middleton, et al.
British Journal of Cancer
|
February 14, 2018
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Victoria K Woodcock, Sally Clive, Richard H Wilson, et al.
Neuro-Oncology
|
April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
Catherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Oncogene
|
April 11, 2003
Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases
Päivi Laiho, Tuija Hienonen, Auli Karhu, et al.
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2016
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
Katy J McCann, Ann Mander, Angelica Cazaly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
Sarah Halford, Gareth J Veal, Stephen R Wedge, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 8, 2005
Refining molecular analysis in the pathways of colorectal carcinogenesis
Andrew Rowan, Sarah Halford, Michelle Gaasenbeek, et al.
British Journal of Cancer
|
February 21, 2020
A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
Rosie McNeillis, Alastair Greystoke, Jon Walton, et al.
British Journal of Cancer
|
March 23, 2016
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
Yvette Drew, Jonathan Ledermann, Geoff Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors
Dan M Patterson, Martin Zweifel, Mark R Middleton, et al.
British Journal of Cancer
|
February 14, 2018
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Victoria K Woodcock, Sally Clive, Richard H Wilson, et al.
Neuro-Oncology
|
April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
Catherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Oncogene
|
April 11, 2003
Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases
Päivi Laiho, Tuija Hienonen, Auli Karhu, et al.
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2016
Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
Katy J McCann, Ann Mander, Angelica Cazaly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
Sarah Halford, Gareth J Veal, Stephen R Wedge, et al.
Page
of 3